The role of intravenous proton pump inhibitors in the modern management of nonvariceal upper gastrointestinal bleeding

Drugs of Today

Volumn 39, Issue SUPPL. A, 2003, Pages 3-10

  Barkun, Allan N ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ACID SECRETION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG COST; DRUG SAFETY; DRUG TOLERABILITY; ENDOSCOPIC THERAPY; GASTRODUODENAL ULCER; HEMOSTASIS; HOSPITALIZATION; HUMAN; MORBIDITY; MORTALITY; RISK FACTOR; TREATMENT OUTCOME; TREATMENT PLANNING; UPPER GASTROINTESTINAL BLEEDING;

ANTI-ULCER AGENTS; ENDOSCOPY, GASTROINTESTINAL; ENZYME INHIBITORS; GASTROINTESTINAL HEMORRHAGE; HUMANS; PROTON PUMPS;

EID: 0037240851     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Longstreth, G.F. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: A population-based study. Am J Gastroenterol 1995, 90(2): 206-10.
2. Cook, D.J., Guyatt, G.H., Salena, B.J., Laine, L.A. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis. Gastroenterology 1992, 102(1): 139-48.
3. Barkun, A.N., Cockeram, A.W., Plourde, V., Fedorak, R.N. Review article: Acid suppression in non-variceal acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 1999, 13(12): 1565-84.
4. Marshall, J.K., Collins, S.M., Gafni, A. Demographic predictors of resource utilization for bleeding peptic ulcer disease: The Ontario GI Bleed Study. J Clin Gastroenterol 1999, 29(2): 165-70.
5. Green, F.W. Jr., Kaplan, M.M., Curtis, L.E., Levine, P.H. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978, 74(1): 38-43.
6. Berstad, A. Does profound acid inhibition improve haemostasis in peptic ulcer bleeding? Scand J Gastroenterol 1997, 32(4): 396-8.
7. Vreeburg, E.M., Levi, M., Rauws, E.A. et al. Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and the beneficial effect of acid suppression. Aliment Pharmacol Ther 2001, 15 (5): 639-46.
8. 2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl J Med 1985, 313(11): 660-6.
9. Walt, R.P., Cottrell, J., Mann, S.G., Freemantle, N.P., Langman, M.J. Continuous intravenous famotidine for haemorrhage from peptic ulcer. Lancet 1992, 340(8827): 1058-62.
10. 2-receptor antagonists in bleeding peptic ulcer. Aliment Pharmacol Ther 2002, 16(6): 1137-42.
11. Merki, H.S., Wilder-Smith, C.H. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing? Gastroenterology 1994, 106(1): 60-4.
12. Brunner, G. et al. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding. Yale J Biol Med 1996, 69: 225-31.
13. Hasselgren, G., Keelan, M., Kirdeikis, P. et al. Optimization of acid suppression for patients with peptic ulcer bleeding: An intragastric pH-metry study with omeprazole. Eur J Gastroenterol Hepatol 1998, 10(7): 601-6.
14. van Rensburg, C.J., Thorpe, A., Warren, B. et al. Intragastric pH in patients with bleeding peptic ulceration during pantoprazole infusion of 8 mg/hour. Gastroenterology 1997, 112(4): A321.
15. Sander, P., Stahlheber-Dilg, B., Ley, L., Lücker, P.W. The pharmacodynamic effects of pantoprazole i.v. vs. ranitidine i.v. after pretreatment with ranitidine p.o. in Helicobacter pylori negative volunteers. Endoscopy 2000, 32(Suppl.): E45.
16. Daneshmend, T.K., Hawkey, C.J., Langman, M.J., Logan, R.F., Long, R.G., Walt, R.P. Omeprazole versus placebo for acute upper gastrointestinal bleeding: Randomised double blind controlled trial. BMJ 1992, 304: 143-7.
17. Hasselgren, G., Lind, T., Lundell, L. et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol 1997, 32(4): 328-33.
18. Schaffalitzky de Muckadell, O.B., Havelund, T., Harling, H. et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol 1997, 32(4): 320-7.
19. Lin, H.J., Lo, W.C., Lee, F.Y., Perng, C.L., Tseng, G.Y. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 1998, 158: 54-8.
20. Lau, J.Y., Sung, J.J., Lee, K.K. et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000, 343: 310-6.
21. Schönekäs, H., Ahrens, H., Pannewick, U. et al. Comparison of two doses of intravenous pantoprazole in peptic ulcer bleeding. Gut 1999, 45(Suppl. V): A104.
22. Zhonglin, Y., Sanren, L., Huiji, W. Effectiveness and safety of pantoprazole i.v. and omeprazole i.v. in the treatment of patients with peptic ulcer bleeding. J Gastroenterol Hepatol 2002, 17(Suppl.): A257.
23. Yang, C.C., Shin, J.S., Lin, X.Z., Hsu, P.I., Chen, K.W., Lin, C.Y. The natural history (fading time) of stigmata of recent hemorrhage in peptic ulcer disease. Gastrointest Endosc 1994, 40(5): 562-6.
24. Lau, J.Y., Chung, S.C., Leung, J.W., Lo, K.K., Yung, M.Y., Li, A.K. The evolution of stigmata of hemorrhage in bleeding peptic ulcers: A sequential endoscopic study. Endoscopy 1998, 30(6): 513-8.
25. Udd, M., Miettinen, P., Palmu, A. et al. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: A prospective randomized double-blind study. Scand J Gastroenterol 2001, 36(12): 1332-8.
26. Herba, K., Kennedy, W., Barkun, A. Cost-effectiveness of iv PPI's in the treatment of non-variceal upper GI bleeding following urgent endoscopy. Can J Gastroenterol 2002, 16(Suppl. A): 87A (Abst 112).
27. Enns, R., Gagnon, Y., Rioux, K., Levy, A. Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 2003, 17: 1-9 (in press).
28. Barkun, A.N., Kennedy, W., Herba, K., Fallone, C. and RUGBE investigators. The cost effectiveness of proton pump inhibitor continuous infusion (IV PPI) administered prior to endoscopy in the treatment of patients with non-variceal upper GI bleeding. Gastroenterology 2002, 122 (4, Suppl. 1): A67 (Abst. 332).
29. Khuroo, M.S., Yattoo, G.N., Javid, G. et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997, 336(15): 1054-8.
30. Javid, G., Masoodi, I., Zaragar, S.A. et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 2001, 111(4): 280-4.
31. Jung, H.K., Son, H-Y., Jung, S-A. et al. Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots. Am J Gastroenterol 2002, 97: 1736-40.
32. Bair, F.D., James, C., Armstrong, D. Maximal acid suppression: Oral vs. intravenous pantoprazole. Gastroenterology 2002, 122(4, Suppl.): T1540.
33. Sabbah, S., Barkun, A., Rahme, E. et al. and RUGBE investigators. High dose intravenous proton pump inhibitors improved outcomes in unselected patients who undergo endoscopy for acute non-variceal upper GI bleeding. Gastroenterology 2002, 122(4, Suppl. 1): A477 (Abst T1543).
34. Sabbah, S., Barkun, A., Rahme, E. et al. and RUGBE investigators. High dose intravenous proton pump inhibitors improved mortality in patients with acute non-variceal upper GI bleeding exhibiting high risk endoscopic stigmata. Am J Gastroenterol 2002, 97(9): S230.